POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.17.2021, 11:32am CEST, WHO):   U.S. 11,954    India 62,224    Brazil 80,609    France 1,867    Turkey 5,955    Russia 13,397    The United Kingdom 7,587    Italy 1,253    Argentina 27,260    Columbia 24,452    Spain 1,607    Germany 1,455    Iran 10,487    Mexico 4,250    Ukraine 1,045    Peru 3,225    Indonesia 9,944    South Africa 8,436    The Netherlands 1,062    Chile 4,322    Philippines 5,414    Iraq 5,139    Pakistan 1,038    Bangladesh 3,956    Japan 1,695    Malaysia 5,150    Nepal 2,014    United Arab Emirates 2,011    Saudi Arabia 1,239    Ecuador 1,806    Bolivia 1,971    Paraguay 2,667    Tunisia 2,091    Costa Rica 1,708    Uruguay 2,797    Kuwait 1,557    Dominican Republic 1,442    Guatemala 1,472    Venezuela 1,233    Honduras 1,003    Oman 2,142    Sri Lanka 2,436    Thailand 2,331    Cuba 1,403    Zambia 2,690    Afghanistan 3,243    Mongolia 2,395    Namibia 1,206    Uganda 1,422    Botswana 1,981    Réunion 1,206    China 188    Singapore 24    New Zealand 2    Australia 17    South Korea 540   

Under-40s in UK to be offered alternative to AstraZeneca jab

Christian Fernsby |
Those under-40s will be offered an alternative to the Oxford-AstraZeneca coronavirus vaccine as a precaution, British health authorities announced Friday.

Article continues below




The latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), an independent expert advisory committee that advises Britain's health departments on immunisation, marks a shift to existing guidance where those aged under 30 were given an alternative to Astrazeneca over blood clotting concerns.

Latest data from the Medicines and Healthcare products Regulatory Agency (MHRA) showed there have been 242 blood clots in combination with low platelets in more than 28 million people who had the AstraZeneca vaccine up to April 28.

Previously, the MHRA had said the balance of risk for the AstraZeneca vaccine against coronavirus is very favourable for older people but "more finely balanced" for younger groups.

The JCVI said an alternative jab should only be given where it does not cause a major delay in immunization as experts fear that a significant delay to the vaccine rollout could increase the risk of a third wave.

The AstraZeneca jab is the only one of the three licensed vaccines that can be distributed at fridge temperature. The JCVI suggested that in some circumstances, AstraZeneca may be the only practical dose to offer.

People who have already had one dose of the AstraZeneca vaccine with no relevant side effects will also be offered it second time around, according to regulators. The benefits of the AstraZeneca vaccine continue to "outweigh the risks for the vast majority of adults", regulators said.

More than 34.9 million people have been given the first jab of the coronavirus vaccine, according to the latest official figures.

Experts have warned that despite progress in vaccine rollout, Britain is "still not out of the woods" amid concerns over new variants, particularly those first emerged in South Africa, Brazil and India, and the third wave of pandemic on the European continent.